134 related articles for article (PubMed ID: 15662120)
21. Flow cytometric analysis of lymph node metastases in advanced ovarian cancer: clinical and biologic significance.
Kimball RE; Schlaerth JB; Kute TE; Schlaerth AC; Santoso J; Ballon SC; Spirtos NM
Am J Obstet Gynecol; 1997 Jun; 176(6):1319-26; discussion 1326-7. PubMed ID: 9215191
[TBL] [Abstract][Full Text] [Related]
22. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of azoxymethane-induced DNA adduct formation by Aloe arborescens var. natalensis.
Shimpo K; Chihara T; Beppu H; Ida C; Kaneko T; Hoshino M; Kuzuya H
Asian Pac J Cancer Prev; 2003; 4(3):247-51. PubMed ID: 14507246
[TBL] [Abstract][Full Text] [Related]
24. Antitumor effects of a natural anthracycline analog (Aloin) involve altered activity of antioxidant enzymes in HeLaS3 cells.
Nićiforović A; Adzić M; Spasić SD; Radojcić MB
Cancer Biol Ther; 2007 Aug; 6(8):1200-5. PubMed ID: 17726368
[TBL] [Abstract][Full Text] [Related]
25. Intratumoral variations in DNA ploidy and s-phase fraction in human breast cancer.
Arnerlöv C; Emdin SO; Cajander S; Bengtsson NO; Tavelin B; Roos G
Anal Cell Pathol; 2001; 23(1):21-8. PubMed ID: 11790856
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of deoxyribonucleic acid ploidy and S-phase fraction as prognostic parameters in advanced epithelial ovarian carcinoma: a prospective study.
Kaern J; Tropé CG; Kristensen GB; Tveit KM; Pettersen EO
Am J Obstet Gynecol; 1994 Feb; 170(2):479-87. PubMed ID: 8116701
[TBL] [Abstract][Full Text] [Related]
27. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.
Fisher B; Gunduz N; Costantino J; Fisher ER; Redmond C; Mamounas EP; Siderits R
Cancer; 1991 Oct; 68(7):1465-75. PubMed ID: 1893345
[TBL] [Abstract][Full Text] [Related]
28. AgNORs in ductal breast cancer: correlation with ploidy and S-phase fraction by DNA flow cytometry.
Borgiani L; Cogorno P; Oliviero J; Toso F; Gambini G; Tunesi G; Canepa M
Eur J Histochem; 1994; 38(2):171-6. PubMed ID: 7524814
[TBL] [Abstract][Full Text] [Related]
29. Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer.
Stanton PD; Cooke TG; Oakes SJ; Winstanley J; Holt S; George WD; Murray GD
Br J Cancer; 1992 Nov; 66(5):925-9. PubMed ID: 1419638
[TBL] [Abstract][Full Text] [Related]
30. Prognostic potential of DNA flow cytometry measurements in node-negative breast cancer patients: preliminary analysis of an intergroup study (INT 0076).
Dressler LG; Eudey L; Gray R; Tormey DC; McGuire WL; Gilchrist KW; Clark GM; Osborne CK; Mansour EG; Abeloff MD
J Natl Cancer Inst Monogr; 1992; (11):167-72. PubMed ID: 1627424
[TBL] [Abstract][Full Text] [Related]
31. DNA ploidy and proliferation heterogeneity in human prostate cancers.
Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
[TBL] [Abstract][Full Text] [Related]
32. Interrelations between cellular DNA content, S-phase fraction, hormone receptor status and age in primary breast cancer. A series of 1,342 consecutively detected tumors. South-East Sweden Breast Cancer Group.
Stål O; Brisfors A; Carstensen J; Ferraud L; Hatschek T; Nordenskjöld B
Acta Oncol; 1992; 31(3):283-92. PubMed ID: 1622647
[TBL] [Abstract][Full Text] [Related]
33. Flow cytometric analysis of DNA and cell proliferation in ovarian tumors.
Christov K; Vassilev N
Cancer; 1988 Jan; 61(1):121-5. PubMed ID: 3334938
[TBL] [Abstract][Full Text] [Related]
34. Aloin: a natural antitumor anthraquinone glycoside with iron chelating and non-atherogenic activities.
Esmat AY; Said MM; Khalil SA
Pharm Biol; 2015 Jan; 53(1):138-46. PubMed ID: 25243866
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of DNA index, multiploidy, and S-phase fraction in ovarian cancer.
Kallioniemi OP; Punnonen R; Mattila J; Lehtinen M; Koivula T
Cancer; 1988 Jan; 61(2):334-9. PubMed ID: 3334968
[TBL] [Abstract][Full Text] [Related]
36. Aloe-emodin modulates PKC isozymes, inhibits proliferation, and induces apoptosis in U-373MG glioma cells.
Acevedo-Duncan M; Russell C; Patel S; Patel R
Int Immunopharmacol; 2004 Dec; 4(14):1775-84. PubMed ID: 15531293
[TBL] [Abstract][Full Text] [Related]
37. Flow cytometric analysis of DNA ploidy, percent S-phase fraction, and total proliferative fraction as prognostic indicators of local control and survival following radiation therapy for prostate carcinoma.
Centeno BA; Zietman AL; Shipley WU; Sobczak ML; Shipley JW; Preffer FI; Boyle BJ; Colvin RB
Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):309-15. PubMed ID: 7928459
[TBL] [Abstract][Full Text] [Related]
38. [DNA ploidy pattern, S-phase fraction as a prognostic factor of breast cancers].
Kimijima I; Katagata N; Tsuchiya A; Takenoshita S
Nihon Rinsho; 2000 Apr; 58 Suppl():401-6. PubMed ID: 11026024
[No Abstract] [Full Text] [Related]
39. DNA ploidy level and S-phase fraction as prognostic factors in breast cancer.
Yokoe T; Izuo M; Ishida T; Iino Y; Kawai T
Jpn J Surg; 1990 Sep; 20(5):491-7. PubMed ID: 2243441
[TBL] [Abstract][Full Text] [Related]
40. [Development of aloin cells and accumulation of anthraquinone in aloe leaf].
Wang TX; Li JY; Shen ZG; Hu ZH
Shi Yan Sheng Wu Xue Bao; 2003 Oct; 36(5):361-7. PubMed ID: 14724948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]